A Project to Study Probiotic Beauty Products on Skin Improvement
NCT ID: NCT05276661
Last Updated: 2022-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2020-05-18
2020-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Evaluation of the Probiotics Containing Skincare Products on Skin
NCT03350893
The Safety and Efficacy Evaluation of Hair Products Containing Probiotics
NCT04566549
The Efficacy Evaluation of TCI604 Probiotic on Intestinal Function Improvement
NCT07135362
Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora
NCT01428999
Probiotics Regulates Skin Care in Children
NCT05005611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Skin hydration (Corneometer CM825, Courage + Khazaka Electroni, Germany), sebum (Callegari 1930, Italy), and inflammation detection (Chroma Meter MM-500, Minolta, Japan) of upper cheek were measured in every subject. The improvement in inflammation was positively correlated with a decrease of a\* value or an increase of L\* value. VISIA® Complexion Analysis (VISIA® Complexion Analysis, U.S.A.) was also employed to measure the skin inflammation, porphyrins numbers and brown spot numbers of whole face. The result was presented as the mean value and the relative percentage (%) to the baseline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"A" gel (TAC/Collagen gel)
The "A" gel (TAC/Collagen gel) was applied on subjects' right face
TAC/Collagen gel
Apply it twice per day for 4 weeks
"B" gel (placebo lotion)
the "B" gel (placebo lotion) on their left face
placebo lotion
Apply it twice per day for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAC/Collagen gel
Apply it twice per day for 4 weeks
placebo lotion
Apply it twice per day for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
3. Female who is pregnant or nursing or planning to become pregnant during the course of the study.
4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
5. Involuntary subject
6. People who is taking chronic disease medication
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glac Biotech Co., Ltd
INDUSTRY
Chia Nan University of Pharmacy & Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chia-Hua Liang, PhD
Role: PRINCIPAL_INVESTIGATOR
Chia Nan University of Pharmacy & Scienc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chia Nan University of Pharmacy & Science
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TSMHIRB-2-R-025-2.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.